IRCT20121216011763N39 IRCT 2019-11-26 Esfahan University of Medical Sciences The effect of phytosomal curcumin on fatty liver Effect of phytosomal curcumin on lipid profile,fasting blood glucose, anthropometric indices, hepatic function and degree of steatosis, and liver fibrosis measured by fibroscan in non-alcoholic fatty liver patients: a double-blind clinical trial 2020-04-20 anticipated 60 Complete https://irct.ir/trial/43730 interventional Randomization: Randomized, Blinding: Double blinded, Placebo: Used, Assignment: Parallel, Purpose: Supportive, Randomization description: Randomly, based on the permuted block randomization method, using blocks of 4 that will be blocked based on gender variables and will be assigned to one of two phytosomal curcumin and placebo groups.The enrolling participants, and assigning participants to the groups will carried out by a trained nutritionist. Researchers will not informed about randomization process until completion of data analyses, Blinding description: This study is a double blind clinical trial (participant, researcher). The phytosomal curcumin supplement and its placebo will be packaged in similar boxes, and the researcher and patients will not be informed of the contents of the packs until the end of the study. N/A Non-alcoholic fatty liver. Intervention 1: Intervention group: phytosomal curcumin, 250 mg oral capsule, once daily for 12 weeks. Intervention 2: Control group: Placebo (maltodextrin) 250 mg orally, once daily for 12 weeks. Yes - There is a plan to make this available What will be shared: The collected deidentified for the primary outcome measure only will be shared. When: 12 months after publication To whom: Available for people working in academic institutions Conditions: To conduct similar studies Where to obtain: askari@mui.ac.ir How to obtain: The data will send as soon as possible, after receiving the request. Comments: